ArticleMedicine2026
Association between blood cadmium and prevalent coronary heart disease in NHANES 2013 to 2014: A cross-sectional study with machine-learning analyses.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cadmium is a toxic environmental metal, but its association with prevalent coronary heart disease (CHD) remains uncertain. We examined whether blood cadmium concentrations were associated with prevalent CHD in US adults and explored machine-learning model performance. This cross-sectional study used data from the National Health and Nutrition Examination Survey 2013 to 2014. Adults aged ≥20 years with complete data on self-reported CHD, blood cadmium, and covariates were included. Blood cadmium was measured by inductively coupled plasma mass spectrometry. Survey-weighted logistic regression was used to assess associations between blood cadmium and prevalent CHD. Sensitivity analyses additionally adjusted for serum cotinine and were repeated in never smokers. Ten machine-learning algorithms were developed to assess discrimination, calibration, and feature importance. Among 2219 participants, higher blood cadmium concentrations were associated with higher odds of prevalent CHD. In the fully adjusted model, each 1-unit increase in ln-transformed blood cadmium was associated with prevalent CHD (odds ratio, 1.38; 95% confidence interval, 1.05-1.81). Compared with the lowest quartile, the highest quartile was associated with higher odds of prevalent CHD (odds ratio, 1.95; 95% confidence interval, 1.25-3.04). The association remained after additional adjustment for serum cotinine but was attenuated in never smokers. The multilayer perceptron showed the best overall discrimination and calibration; age ranked first and blood cadmium ranked second by mean absolute Shapley Additive Explanations value. Higher blood cadmium concentrations were associated with higher odds of prevalent CHD in this cross-sectional analysis. These findings should be interpreted cautiously because residual smoking-related confounding remains possible and the CHD outcome was self-reported.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.